Overview
McDermott Will & Emery has advised Owkin on the financing to launch Bioptimus, the first universal AI foundation model for biology.
Bioptimus will connect the different scales of biology with generative AI; from molecules to cells, tissues and whole organisms, to fuel scientific breakthroughs and accelerate innovation in biomedicine and beyond.
The French startup has launched with a seed funding of USD 35 million, led by Sofinnova Partners, with Bpifrance Large Venture, and additional funding from global technology VCs
The McDermott that advised Owkin comprised:
- Emmanuelle Trombe, partner, Lucie Martin, Natacha Vasak and Alice Villagrasa, associates, on Corporate aspects
- Lorraine Maisnier-Boche, Counsel, on Data aspects
- Côme de Saint-Vincent, Counsel, on Tax aspects
About McDermott
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
